Hackensack Meridian Health, Inc.
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 10, 2026), Hackensack Meridian Health, Inc. reported 7 stock positions worth $1.1 billion. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 34.7% of the portfolio, followed by iShares MSCI Eafe ETF (EFA, 21.4%) and iShares Russell 1000 Growth (IWF, 14.5%). Compared with Q3 2025, it opened 2 new positions, sold out of 1 and added to 1. The biggest buy was a new position in iShares Russell 1000 Growth (IWF) and the biggest sale an exit from iShares TR.
- Most Recent 13F
- Q2 2026
- Location
- EDISON, NJ
- CIK
- 0001851813
- Portfolio Value
- $1.1B (Q4 2025)
- SEC Filing
- 0001851813-26-000003 ↗ filed Feb 10, 2026
Holdings Value
Holdings 7 stocks · $1.1B
| SPY SS SPDR S&P 500 ETF Trust-US | 34.69% | 558,000 | $380.5M | Add +10.4% |
| EFA iShares MSCI Eafe ETF | 21.37% | 2,440,932 | $234.4M | No change |
| IWF iShares Russell 1000 Growth | 14.54% | 337,000 | $159.5M | New |
| IEMG iShares Core MSCI Emerging | 13.39% | 2,185,000 | $146.9M | No change |
| GNR State Street SPDR S&P Global | 9.10% | 1,606,000 | $99.8M | No change |
| EFV iShares MSCI Eafe Value ETF | 5.83% | 895,000 | $63.9M | New |
| ACWI iShares MSCI Acwi ETF | 1.10% | 85,000 | $12.0M | No change |
Portfolio Sells Q3 2025 → Q4 2025
| ISHARES TR | Sold out | 0.00% | −16.22 |
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $1.5B | SPY, EFA, IEMG, IWF, EFV |
| Q1 2026 | 7 | $1.1B | SPY, EFA, IEMG, IWF, GNR |
| Q4 2025 | 7 | $1.1B | SPY, EFA, IWF, IEMG, GNR |
| Q3 2025 | 6 | $973.4M | SPY, EFA, ISHARES TR, IEMG, GNR |
| Q2 2025 | 6 | $902.8M | SPY, EFA, ISHARES TR, IEMG, GNR |
| Q1 2025 | 6 | $878.9M | SPY, EFA, IEMG, ISHARES TR, GNR |
| Q4 2024 | 6 | $841.9M | SPY, EFA, ISHARES TR, ACWI, GNR |
| Q3 2024 | 6 | $973.9M | SPY, ISHARES TR, EFA, ACWI, GNR |
| Q2 2024 | 6 | $750.2M | SPY, ACWI, IWD, GNR, EFA |
| Q1 2024 | 6 | $743.9M | SPY, ACWI, IWD, GNR, EFA |